A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females

Clinical trial NCT05584332 · TERMINATED

Trial details

NCT number: NCT05584332
Sponsor: Shanghai Bovax Biotechnology Co., Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Cancer Genital Wart CIN1 CIN2 CIN3 Vain I Vain III Vin I Vin II Vin III AIS VAIN - Vaginal Intraepithelial Neoplasia 2

Start date: 2022-12-09
Primary completion: 2023-03-23
Enrollment: 3131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.